See more : U3O8 Corp. (UWEFF) Income Statement Analysis – Financial Results
Complete financial analysis of Sea Mild Biotechnology Co., Ltd. (7516.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sea Mild Biotechnology Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- GMO Financial Gate, Inc. (4051.T) Income Statement Analysis – Financial Results
- Marimekko Oyj (0JX9.L) Income Statement Analysis – Financial Results
- Accelleron Industries AG (ACLLY) Income Statement Analysis – Financial Results
- RingCentral, Inc. (RNG) Income Statement Analysis – Financial Results
- Luoyang Glass Company Limited (1108.HK) Income Statement Analysis – Financial Results
Sea Mild Biotechnology Co., Ltd. (7516.TWO)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.seamild.com.tw
About Sea Mild Biotechnology Co., Ltd.
Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. Sea Mild Biotechnology Co., Ltd. is headquartered in Taoyuan City, Taiwan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 257.02M | 202.65M | 163.82M | 207.88M | 214.14M | 215.07M | 168.25M | 227.71M |
Cost of Revenue | 200.65M | 174.59M | 150.87M | 184.95M | 211.24M | 158.08M | 141.37M | 173.25M |
Gross Profit | 56.37M | 28.06M | 12.95M | 22.93M | 2.90M | 56.99M | 26.89M | 54.47M |
Gross Profit Ratio | 21.93% | 13.85% | 7.91% | 11.03% | 1.36% | 26.50% | 15.98% | 23.92% |
Research & Development | 3.38M | 2.97M | 4.90M | 5.00M | 7.84M | 2.79M | 2.59M | 2.98M |
General & Administrative | 20.41M | 16.07M | 21.82M | 29.14M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 27.74M | 29.14M | 25.90M | 32.00M | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 48.15M | 37.07M | 40.04M | 54.51M | 97.59M | 61.81M | 54.85M | 84.85M |
Other Expenses | 4.83M | -8.91M | -9.28M | -9.60M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 56.37M | 40.04M | 44.94M | 59.51M | 105.44M | 64.60M | 57.44M | 87.83M |
Cost & Expenses | 252.18M | 214.63M | 195.81M | 244.45M | 316.67M | 222.67M | 198.80M | 261.07M |
Interest Income | 296.00K | 84.00K | 106.00K | 41.00K | 150.00K | 53.00K | 14.00K | 23.00K |
Interest Expense | 965.00K | 681.00K | 832.00K | 1.12M | 1.66M | 1.54M | 2.55M | 2.28M |
Depreciation & Amortization | 14.49M | 15.17M | 20.84M | 20.88M | 20.56M | 4.12M | 6.80M | 6.45M |
EBITDA | 21.58M | -5.63M | -20.33M | -25.25M | -121.26M | -2.34M | 22.27M | -26.35M |
EBITDA Ratio | 8.40% | 1.57% | -6.81% | -7.55% | -38.28% | -1.62% | -14.12% | -11.82% |
Operating Income | 4.83M | -11.98M | -31.99M | -36.57M | -102.53M | -7.60M | -30.55M | -33.36M |
Operating Income Ratio | 1.88% | -5.91% | -19.53% | -17.59% | -47.88% | -3.53% | -18.16% | -14.65% |
Total Other Income/Expenses | 1.30M | -9.50M | -10.01M | -10.68M | -40.94M | -402.00K | 43.47M | -1.72M |
Income Before Tax | 6.13M | -21.48M | -42.00M | -47.25M | -143.47M | -8.00M | 12.92M | -35.08M |
Income Before Tax Ratio | 2.39% | -10.60% | -25.64% | -22.73% | -67.00% | -3.72% | 7.68% | -15.40% |
Income Tax Expense | -55.00K | -103.00K | 10.06M | 8.25M | 15.65M | -8.07M | -4.92M | -5.23M |
Net Income | 6.19M | -21.38M | -52.05M | -55.50M | -159.13M | 66.00K | 17.84M | -29.84M |
Net Income Ratio | 2.41% | -10.55% | -31.77% | -26.70% | -74.31% | 0.03% | 10.60% | -13.10% |
EPS | 0.32 | -1.11 | -2.70 | -2.87 | -8.34 | 0.00 | 1.15 | -1.93 |
EPS Diluted | 0.32 | -1.11 | -2.70 | -2.87 | -8.34 | 0.00 | 1.15 | -1.93 |
Weighted Avg Shares Out | 19.31M | 19.31M | 19.31M | 19.31M | 19.09M | 13.40M | 15.46M | 15.46M |
Weighted Avg Shares Out (Dil) | 19.31M | 19.31M | 19.31M | 19.31M | 19.09M | 13.40M | 15.46M | 15.46M |
Source: https://incomestatements.info
Category: Stock Reports